Literature DB >> 24690272

Exercise, APOE genotype, and the evolution of the human lifespan.

David A Raichlen1, Gene E Alexander2.   

Abstract

Humans have exceptionally long lifespans compared with other mammals. However, our longevity evolved when our ancestors had two copies of the apolipoprotein E (APOE) ɛ4 allele, a genotype that leads to a high risk of Alzheimer's disease (AD), cardiovascular disease, and increased mortality. How did human aging evolve within this genetic constraint? Drawing from neuroscience, anthropology, and brain-imaging research, we propose the hypothesis that the evolution of increased physical activity approximately 2 million years ago served to reduce the amyloid plaque and vascular burden of APOE ɛ4, relaxing genetic constraints on aging. This multidisciplinary approach links human evolution with health and provides a complementary perspective on aging and neurodegenerative disease that may help identify key mechanisms and targets for intervention.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; aerobic fitness; aging; apolipoprotein; dementia; vitamin D

Mesh:

Substances:

Year:  2014        PMID: 24690272      PMCID: PMC4066890          DOI: 10.1016/j.tins.2014.03.001

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  118 in total

1.  Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study.

Authors:  K I Erickson; C A Raji; O L Lopez; J T Becker; C Rosano; A B Newman; H M Gach; P M Thompson; A J Ho; L H Kuller
Journal:  Neurology       Date:  2010-10-13       Impact factor: 9.910

2.  APOE distribution in world populations with new data from India and the UK.

Authors:  P P Singh; M Singh; S S Mastana
Journal:  Ann Hum Biol       Date:  2006 May-Jun       Impact factor: 1.533

3.  SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease.

Authors:  E R Martin; E H Lai; J R Gilbert; A R Rogala; A J Afshari; J Riley; K L Finch; J F Stevens; K J Livak; B D Slotterbeck; S H Slifer; L L Warren; P M Conneally; D E Schmechel; I Purvis; M A Pericak-Vance; A D Roses; J M Vance
Journal:  Am J Hum Genet       Date:  2000-06-21       Impact factor: 11.025

4.  Older age becomes common late in human evolution.

Authors:  Rachel Caspari; Sang-Hee Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-13       Impact factor: 11.205

5.  Neuroanatomical correlates of aging, cardiopulmonary fitness level, and education.

Authors:  Brian A Gordon; Elena I Rykhlevskaia; Carrie R Brumback; Yukyung Lee; Steriani Elavsky; James F Konopack; Edward McAuley; Arthur F Kramer; Stanley Colcombe; Gabriele Gratton; Monica Fabiani
Journal:  Psychophysiology       Date:  2008-07-04       Impact factor: 4.016

Review 6.  Apolipoprotein e sets the stage: response to injury triggers neuropathology.

Authors:  Robert W Mahley; Yadong Huang
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

7.  Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.

Authors:  R J Caselli; E M Reiman; D Osborne; J G Hentz; L C Baxter; J L Hernandez; G G Alexander
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

8.  Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

Authors:  Joan Lindsay; Danielle Laurin; René Verreault; Réjean Hébert; Barbara Helliwell; Gerry B Hill; Ian McDowell
Journal:  Am J Epidemiol       Date:  2002-09-01       Impact factor: 4.897

9.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

10.  Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates.

Authors:  Kewei Chen; Eric M Reiman; Gene E Alexander; Richard J Caselli; Richard Gerkin; Daniel Bandy; Alisa Domb; David Osborne; Nick Fox; William R Crum; Ann M Saunders; John Hardy
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

View more
  49 in total

1.  Human-specific derived alleles of CD33 and other genes protect against postreproductive cognitive decline.

Authors:  Flavio Schwarz; Stevan A Springer; Tasha K Altheide; Nissi M Varki; Pascal Gagneux; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

2.  Loss of CMAH during Human Evolution Primed the Monocyte-Macrophage Lineage toward a More Inflammatory and Phagocytic State.

Authors:  Jonathan J Okerblom; Flavio Schwarz; Josh Olson; William Fletes; Syed Raza Ali; Paul T Martin; Christopher K Glass; Victor Nizet; Ajit Varki
Journal:  J Immunol       Date:  2017-02-01       Impact factor: 5.422

Review 3.  Adaptive Capacity: An Evolutionary Neuroscience Model Linking Exercise, Cognition, and Brain Health.

Authors:  David A Raichlen; Gene E Alexander
Journal:  Trends Neurosci       Date:  2017-06-10       Impact factor: 13.837

Review 4.  Genetics and functional imaging: effects of APOE, BDNF, COMT, and KIBRA in aging.

Authors:  Goran Papenberg; Alireza Salami; Jonas Persson; Ulman Lindenberger; Lars Bäckman
Journal:  Neuropsychol Rev       Date:  2015-02-10       Impact factor: 7.444

Review 5.  The Oxygen Paradox, the French Paradox, and age-related diseases.

Authors:  Joanna M S Davies; Josiane Cillard; Bertrand Friguet; Enrique Cadenas; Jean Cadet; Rachael Cayce; Andrew Fishmann; David Liao; Anne-Laure Bulteau; Frédéric Derbré; Amélie Rébillard; Steven Burstein; Etienne Hirsch; Robert A Kloner; Michael Jakowec; Giselle Petzinger; Delphine Sauce; Florian Sennlaub; Isabelle Limon; Fulvio Ursini; Matilde Maiorino; Christina Economides; Christian J Pike; Pinchas Cohen; Anne Negre Salvayre; Matthew R Halliday; Adam J Lundquist; Nicolaus A Jakowec; Fatima Mechta-Grigoriou; Mathias Mericskay; Jean Mariani; Zhenlin Li; David Huang; Ellsworth Grant; Henry J Forman; Caleb E Finch; Patrick Y Sun; Laura C D Pomatto; Onnik Agbulut; David Warburton; Christian Neri; Mustapha Rouis; Pierre Cillard; Jacqueline Capeau; Jean Rosenbaum; Kelvin J A Davies
Journal:  Geroscience       Date:  2017-12-21       Impact factor: 7.713

Review 6.  Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence.

Authors:  Yu Yamazaki; Meghan M Painter; Guojun Bu; Takahisa Kanekiyo
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

7.  Differential associations of engagement in physical activity and estimated cardiorespiratory fitness with brain volume in middle-aged to older adults.

Authors:  David A Raichlen; Yann C Klimentidis; Pradyumna K Bharadwaj; Gene E Alexander
Journal:  Brain Imaging Behav       Date:  2020-10       Impact factor: 3.978

Review 8.  Transcriptional Effects of ApoE4: Relevance to Alzheimer's Disease.

Authors:  Veena Theendakara; Clare A Peters-Libeu; Dale E Bredesen; Rammohan V Rao
Journal:  Mol Neurobiol       Date:  2017-09-06       Impact factor: 5.590

9.  Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer's Disease.

Authors:  Suresh B Rangasamy; Grant T Corbett; Avik Roy; Khushbu K Modi; David A Bennett; Elliott J Mufson; Sankar Ghosh; Kalipada Pahan
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

10.  Decoding the molecular evolution of human cognition using comparative genomics.

Authors:  Noriyoshi Usui; Marissa Co; Genevieve Konopka
Journal:  Brain Behav Evol       Date:  2014-09-20       Impact factor: 1.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.